TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20183413

Group type: EXPERIMENTAL
Intervention: Condensed Seeking Safety intervention (six sessions)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard chemical dependence intervention
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Condensed Seeking Safety intervention
Number of subjects: 104
Study: 17708865

Group type: EXPERIMENTAL
Intervention: Low lactose milk
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Lactase-fermented milk
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Coinfected milk
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Yogurt
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Milk with meal
Number of subjects: 68
Study: 15510531

Group type: EXPERIMENTAL
Intervention: Nurse-coaching intervention (5 individualized sessions and 2 follow-up phone calls over 6 months)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Nurse-coaching intervention
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 53
Study: 11900312

Group type: EXPERIMENTAL
Intervention: Active PEMF treatment
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 10089797

Group type: EXPERIMENTAL
Intervention: Provox voice prosthesis
Number of subjects: 15

Group type: COMPARATOR
Intervention: LR Groningen prosthesis
Number of subjects: 15
Study: 8092203

Group type: EXPERIMENTAL
Intervention: Median episiotomy
Number of subjects: 697

Group type: COMPARATOR
Intervention: Intact perineum or spontaneous perineal tears
Number of subjects: 697

Group type: COMPARATOR
Intervention: Intact perineum
Number of subjects: 697

Group type: COMPARATOR
Intervention: Spontaneous perineal tears
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Episiotomy
Number of subjects: 697

Group type: COMPARATOR
Intervention: All perineal groups
Number of subjects: 697
Study: 3378381

Group type: EXPERIMENTAL
Intervention: 20 mg naloxone
Number of subjects: 0
Study: 29413790

Group type: EXPERIMENTAL
Intervention: Prowling with proprioceptive training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Routine physiotherapy
Number of subjects: 32
Study: 28209466

Group type: EXPERIMENTAL
Intervention: Cavosonstat (N91115)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 25381314

Group type: EXPERIMENTAL
Intervention: Risk factor screening for ischemic heart disease (IHD)
Number of subjects: 60915
Study: 23562589

Group type: EXPERIMENTAL
Intervention: UCu200
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: TCu380A
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: medicated γ-IUD
Number of subjects: 1800
Study: 21493648

Group type: EXPERIMENTAL
Intervention: S/GSK1349572 50 mg with multivitamin (MVI; One A Day Maximum)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: S/GSK1349572 50 mg with liquid antacid (Maalox Advanced Maximum Strength)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: S/GSK1349572 50 mg 2 h before an antacid
Number of subjects: 28

Group type: COMPARATOR
Intervention: S/GSK1349572 alone
Number of subjects: 28
Study: 19625582

Group type: EXPERIMENTAL
Intervention: Computer-based reminders to assess HIV risk behaviours or to offer HIV testing; feedback on adherence to reminders provided.
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control group providers tested 1.0% (n = 67) and 1.4% (n = 106) of patients in the preintervention and intervention period, respectively.
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Reminders to test for HIV versus reminders to perform risk assessment.
Number of subjects: 5
Study: 17110827

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (3 g daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (vegetable oil)
Number of subjects: 24
Study: 15655266

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 64
Study: 11696730

Group type: EXPERIMENTAL
Intervention: Intrarectal 2% lidocaine gel
Number of subjects: 108

Group type: COMPARATOR
Intervention: Intrarectal lubricant alone
Number of subjects: 108
Study: 9127776

Group type: EXPERIMENTAL
Intervention: SCS plus PGE1 (n = 45 patients)
Number of subjects: 86

Group type: COMPARATOR
Intervention: PGE1 (n = 41 patients)
Number of subjects: 86
Study: 2162027

Group type: EXPERIMENTAL
Intervention: Rhesus rotavirus vaccine serotype 3 (RRV) 10(5) pfu
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Rhesus rotavirus vaccine serotype 3 (RRV) 10(4) pfu
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Rhesus rotavirus vaccine serotype 3 (RRV) 10(3) pfu
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Infant formula as buffer before vaccination (10(4) pfu group)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Partially breast-fed or formula-fed (10(4) pfu group)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 386961

Group type: EXPERIMENTAL
Intervention: Erbium-169 citrate
Number of subjects: 24

Group type: COMPARATOR
Intervention: Methylprednisolone acetate
Number of subjects: 24
Study: 31126566

Group type: EXPERIMENTAL
Intervention: Lentil savigh (roasted lentil flour) 30 grams daily (three 10-gram sachets in the morning)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Tranexamic acid 500 mg every eight hours
Number of subjects: 54
Study: 28754834

Group type: EXPERIMENTAL
Intervention: Management program comprising specialist review of care plans and nurse education in addition to usual care
Number of subjects: 563

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Management program
Number of subjects: 563
Study: 25871542

Group type: EXPERIMENTAL
Intervention: AeroEclipse nebulizer
Number of subjects: 46

Group type: COMPARATOR
Intervention: Wright nebulizer
Number of subjects: 46
Study: 24636170

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation via intraoral approach with a single monocortical miniplate (group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open reduction and internal fixation via extraoral approach with an inferior border plate (group B)
Number of subjects: 0
Study: 22330824

Group type: EXPERIMENTAL
Intervention: 1500 mg V0191 once daily for 24 weeks
Number of subjects: 242

Group type: COMPARATOR
Intervention: Matching placebo once daily for 24 weeks
Number of subjects: 242
Study: 20606093

Group type: EXPERIMENTAL
Intervention: gemcitabine plus cetuximab
Number of subjects: 745

Group type: COMPARATOR
Intervention: gemcitabine alone
Number of subjects: 745
Study: 17617941

Group type: EXPERIMENTAL
Intervention: High tomato diet (400 ml tomato juice and 30 mg tomato ketchup daily)
Number of subjects: 21
Study: 15616054

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 50
Study: 12065987

Group type: EXPERIMENTAL
Intervention: Standard surgical treatments for intervertebral disc herniation
Number of subjects: 1170

Group type: EXPERIMENTAL
Intervention: Standard surgical treatments for spinal stenosis
Number of subjects: 1170

Group type: EXPERIMENTAL
Intervention: Standard surgical treatments for degenerative spondylolisthesis
Number of subjects: 1170

Group type: COMPARATOR
Intervention: Nonsurgical treatments for intervertebral disc herniation
Number of subjects: 1170

Group type: COMPARATOR
Intervention: Nonsurgical treatments for spinal stenosis
Number of subjects: 1170

Group type: COMPARATOR
Intervention: Nonsurgical treatments for degenerative spondylolisthesis
Number of subjects: 1170
Study: 10188612

Group type: EXPERIMENTAL
Intervention: Custom-contoured cushion surface shapes generated with a seated-buttock contour gauge.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Flat foam cushions.
Number of subjects: 42
Study: 8882120

Group type: EXPERIMENTAL
Intervention: Asbestos cement workers (30 subjects)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Asbestos cement workers with effects related to asbestos (11 subjects with asbestosis)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Asbestos cement workers with asbestosis (11 subjects)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Asbestos cement workers with effects related to asbestos (11 subjects)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Lung cinescintigraphy
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Lung cinescintigraphic variables
Number of subjects: 39
Study: 1993636

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Comparison groups
Number of subjects: 25
Study: 6831838

Group type: EXPERIMENTAL
Intervention: Aminophylline administered intravenously prior to, during and/or after fatigue
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 3
Study: 29858393

Group type: EXPERIMENTAL
Intervention: Lumen-apposing metal stents (LAMS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Plastic stents
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: LAMS
Number of subjects: 60
Study: 29452728

Group type: EXPERIMENTAL
Intervention: Advance Care Planning (ACP) intervention
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Surrogates post-ACP intervention
Number of subjects: 235
Study: 26307186

Group type: EXPERIMENTAL
Intervention: FORE-SIGHT ELITE cerebral oximeter
Number of subjects: 20

Group type: COMPARATOR
Intervention: INVOS 5100C cerebral oximeter
Number of subjects: 20
Study: 25092964

Group type: EXPERIMENTAL
Intervention: frovatriptan 2.5 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: rizatriptan 10 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: frovatriptan
Number of subjects: 18
Study: 22640983

Group type: EXPERIMENTAL
Intervention: Basic model (age, parental/sibling history of diabetes, smoking status, body mass index, hypertension)
Number of subjects: 6342

Group type: EXPERIMENTAL
Intervention: Clinical model 1 (basic model + fasting plasma glucose, high-density lipoprotein-cholesterol, triglycerides)
Number of subjects: 6342

Group type: EXPERIMENTAL
Intervention: Clinical model 2 (clinical model 1 + glycated hemoglobin (HbA(1c)))
Number of subjects: 6342
Study: 19640784

Group type: EXPERIMENTAL
Intervention: iTBS with 4mg nicotine
Number of subjects: 10

Group type: COMPARATOR
Intervention: iTBS with placebo
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nicotine alone (control experiment)
Number of subjects: 10
Study: 17487772

Group type: EXPERIMENTAL
Intervention: Iloprost
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Papaverine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 28

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 28
Study: 14678373

Group type: EXPERIMENTAL
Intervention: Ro 115-1240 (1.5 mg twice daily for 2 or 4 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 11743658

Group type: EXPERIMENTAL
Intervention: CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)
Number of subjects: 269

Group type: COMPARATOR
Intervention: MACOP-B (methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisone, bleomycin)
Number of subjects: 269
Study: 9434669

Group type: EXPERIMENTAL
Intervention: Multidisciplinary team interventions in experimental homes
Number of subjects: 1854

Group type: COMPARATOR
Intervention: Control homes
Number of subjects: 1854
Study: 10628245

Group type: EXPERIMENTAL
Intervention: Scotopic dim flash
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Scotopic bright flash
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Flicker response
Number of subjects: 70
Study: 2201425

Group type: EXPERIMENTAL
Intervention: Megestrol acetate
Number of subjects: 58

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 58
Study: 215795

Group type: EXPERIMENTAL
Intervention: Pivmecillinam (PMPC) 200 mg per day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nalidixic acid (NA) 2000 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pivmecillinam (PMPC)
Number of subjects: 0
Study: 31657024

Group type: EXPERIMENTAL
Intervention: Crisaborole ointment, 2%
Number of subjects: 32

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 32
Study: 31484770

Group type: EXPERIMENTAL
Intervention: Active instruction (following best practices in the discipline)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive instruction (lectures by experienced and highly rated instructors)
Number of subjects: 0
Study: 28373701

Group type: EXPERIMENTAL
Intervention: Rd continuous
Number of subjects: 2993
Study: 25423571

Group type: EXPERIMENTAL
Intervention: Intraduodenal glucose infusion (30 g glucose and 3 g 3‐O‐methylglucose)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intraduodenal glucose infusion
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: SGLT‐1 expression
Number of subjects: 28
Study: 24069753

Group type: EXPERIMENTAL
Intervention: Immediate postpartum insertion (10 minutes to 48 hours)
Number of subjects: 115

Group type: COMPARATOR
Intervention: 6 weeks postpartum insertion
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Overall satisfaction with the intrauterine device
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Feasibility of recruiting and consenting women
Number of subjects: 115
Study: 21227548

Group type: EXPERIMENTAL
Intervention: Rivastigmine transdermal patch (non-titrated, 9.5 mg/day for 3 months)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Rivastigmine transdermal patch (titrated, 4.6 mg/day for 1 month followed by 9.5 mg/day for 2 months)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Rivastigmine capsules (6-12 mg/day for 3 months)
Number of subjects: 140
Study: 19672164

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 300

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Dreamers (both groups)
Number of subjects: 300
Study: 16112255

Group type: EXPERIMENTAL
Intervention: Meningococcal C conjugate vaccine (MCC-TT)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Hib IgG geometric mean concentration (GMC)
Number of subjects: 106
Study: 15131544

Group type: EXPERIMENTAL
Intervention: abciximab (24-hour or 48-hour infusion)
Number of subjects: 7800

Group type: EXPERIMENTAL
Intervention: abciximab (48-hour infusion)
Number of subjects: 7800

Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 7800

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 7800
Study: 11239100

Group type: EXPERIMENTAL
Intervention: Court-ordered treatment (78 participants)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Enhanced-service package only (64 participants)
Number of subjects: 142
Study: 9404911

Group type: EXPERIMENTAL
Intervention: Oxytocin induction
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Vaginal prostaglandin E2 gel followed by oxytocin
Number of subjects: 96

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 96
Study: 8235813

Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 208
Study: 2897462

Group type: EXPERIMENTAL
Intervention: Etintidine (400 mg)
Number of subjects: 12
Study: 30499485

Group type: EXPERIMENTAL
Intervention: Laser electrophoresis of herbal extracts (equisetum and hypericum)
Number of subjects: 44

Group type: COMPARATOR
Intervention: NSAID-based anti-inflammatory therapy
Number of subjects: 44
Study: 27538683

Group type: EXPERIMENTAL
Intervention: Nebulized VRP700 (1.0 mg/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9%)
Number of subjects: 8
Study: 24872365

Group type: EXPERIMENTAL
Intervention: Tendon tears (painful rotator cuff tears)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control tissue (posttraumatic shoulder instability)
Number of subjects: 0
Study: 22339945

Group type: EXPERIMENTAL
Intervention: Zirconia copings generated with the Procera system (group P)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Zirconia copings generated with the Lava system (group L)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Porcelain-fused-to-metal single-unit posterior FDPs (group C)
Number of subjects: 60
Study: 20372053

Group type: EXPERIMENTAL
Intervention: Intradermal vaccine (9 microg of haemagglutinin per strain)
Number of subjects: 2255

Group type: COMPARATOR
Intervention: Intramuscular control vaccine (15 microg haemagglutinin per strain)
Number of subjects: 2255

Group type: EXPERIMENTAL
Intervention: Intradermal vaccine
Number of subjects: 2255

Group type: COMPARATOR
Intervention: Intramuscular control vaccine
Number of subjects: 2255
Study: 18930036

Group type: EXPERIMENTAL
Intervention: Faces (negative emotional faces: angry and fearful)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Shapes (geometric shapes)
Number of subjects: 14
Study: 16154479

Group type: EXPERIMENTAL
Intervention: CFC MDI (salmeterol 25 microg, FPM 14 microg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HFA MDI (salmeterol 25 microg, FPM 7 microg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (CFC MDI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CFC MDI vs HFA MDI
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CFC MDI and HFA MDI
Number of subjects: 40
Study: 11989850

Group type: EXPERIMENTAL
Intervention: Spiral computed tomography (S-CT) assessment of tracheal stenoses
Number of subjects: 54

Group type: COMPARATOR
Intervention: Normal controls (no intervention)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Phantom studies
Number of subjects: 54
Study: 10435478

Group type: EXPERIMENTAL
Intervention: PEFc (corrected Peak Expiratory Flow)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: FEV1
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: PEFnc (non-corrected Peak Expiratory Flow)
Number of subjects: 57
Study: 7759396

Group type: EXPERIMENTAL
Intervention: Gentamicin 4.5 mg/kg/day, once daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gentamicin 4.5 mg/kg/day, thrice daily
Number of subjects: 50
Study: 2186304

Group type: EXPERIMENTAL
Intervention: Colloidal Bismuth Subcitrate (CBS, DE‐NOL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ranitidine (RN)
Number of subjects: 0
Study: 4578364

Group type: EXPERIMENTAL
Intervention: Clofibrate 1.6 g daily
Number of subjects: 15000

Group type: COMPARATOR
Intervention: Olive oil capsules (300-350 mg)
Number of subjects: 15000
Study: 30264242

Group type: EXPERIMENTAL
Intervention: Debridement and hinged ankle distraction
Number of subjects: 50

Group type: COMPARATOR
Intervention: Debridement alone
Number of subjects: 50
Study: 28249847

Group type: EXPERIMENTAL
Intervention: Clinical trial question prompt list (QPL)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control (no QPL)
Number of subjects: 88
Study: 26619553

Group type: EXPERIMENTAL
Intervention: Syndrome differentiation treatment group
Number of subjects: 81

Group type: COMPARATOR
Intervention: Basic treatment group
Number of subjects: 81

Group type: COMPARATOR
Intervention: Disease differentiation treatment group
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 81
Study: 24479280

Group type: EXPERIMENTAL
Intervention: Citrus tea
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fruity tea
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Black tea
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Floral tea
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Green tea
Number of subjects: 6
Study: 22153519

Group type: EXPERIMENTAL
Intervention: Menhaden oil (DHA and EPA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Soybean oil (control)
Number of subjects: 12
Study: 19944875

Group type: EXPERIMENTAL
Intervention: Mapleson‐C manual hyperinflation circuit
Number of subjects: 12

Group type: COMPARATOR
Intervention: Magill manual hyperinflation circuit
Number of subjects: 12
Study: 16686557

Group type: EXPERIMENTAL
Intervention: High-intensity strength training
Number of subjects: 59

Group type: COMPARATOR
Intervention: Stretching and aerobic exercising
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Progressive strength training
Number of subjects: 59
Study: 15295415

Group type: EXPERIMENTAL
Intervention: Intensive medical therapy
Number of subjects: 728

Group type: EXPERIMENTAL
Intervention: Coronary revascularization
Number of subjects: 728
Study: 11764421

Group type: EXPERIMENTAL
Intervention: Open-wedge osteotomy hemicallotasis (HCO)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional high tibial osteotomy (DMO)
Number of subjects: 50
Study: 9236641

Group type: EXPERIMENTAL
Intervention: Oxytocin (Partocon 10 IU)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Saline solution (0.9%)
Number of subjects: 1000
Study: 11767422

Group type: EXPERIMENTAL
Intervention: 60% nitrous oxide in oxygen
Number of subjects: 100

Group type: COMPARATOR
Intervention: 100% oxygen
Number of subjects: 100
Study: 3661527

Group type: EXPERIMENTAL
Intervention: 34-item food frequency instrument
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Limiting the instrument to top 15 foods
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Limiting the instrument to top 10 foods
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Limiting the instrument to top 5 foods
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Rating all portions as 'medium'
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 18-item instrument (rating portion sizes in ounces or cups)
Number of subjects: 37
Study: 29426359

Group type: EXPERIMENTAL
Intervention: Isometric handgrip (IHG) home training (30% of maximum grip strength for a total of 8 min per day per hand) three times a week for 20 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care (hypertension guidelines on lifestyle changes)
Number of subjects: 50
Study: 26419735

Group type: EXPERIMENTAL
Intervention: Instrumental Reminiscence Intervention‐Hong Kong (IRI‐HK)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 114
Study: 25917814

Group type: EXPERIMENTAL
Intervention: 15-month supervised multimodal exercise program (n = 56), 60 minutes once a week at moderate intensity (3.84-4.84 MET-hour)
Number of subjects: 85

Group type: COMPARATOR
Intervention: No intervention (control group, n = 29)
Number of subjects: 85
Study: 23605469

Group type: EXPERIMENTAL
Intervention: Test formulation of olanzapine 10 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference formulation of olanzapine 10 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Test vs. Reference formulation
Number of subjects: 24